ArticleOncoimmunology2022

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis.

Ángela Bella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.